Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2005
05/12/2005WO2005043169A1 Diagnosis of acute myocardial, ischaemic diseases by means of a combination of markers
05/12/2005WO2005043168A2 Method for distinguishing aml-specific flt3 length mutations from tkd mutations
05/12/2005WO2005043167A2 Method for distinguishing aml subtypes with differents gene dosages
05/12/2005WO2005043166A1 Diagnostic for uterine gland cancer and method of detecting gland cancer cell
05/12/2005WO2005043165A2 Specific method for cancer detection
05/12/2005WO2005043164A2 Method for distinguishing cbf-positive aml subtypes from cbf-negative aml subtypes
05/12/2005WO2005043163A2 Method for distinguishing who classified aml subtypes
05/12/2005WO2005043162A2 Method for distinguishing mll-ptd-positive aml from other aml subtypes
05/12/2005WO2005043161A2 Method for distinguishing leukemia subtypes
05/12/2005WO2005043160A2 Ultrasensitive biochemical sensing platform
05/12/2005WO2005043159A1 Water-soluble compound
05/12/2005WO2005043158A1 Recombined cell system for deorphanizing g protein-coupled receptors
05/12/2005WO2005043157A2 Optical detector of organic analyte
05/12/2005WO2005043156A1 Coagulation detection
05/12/2005WO2005043153A1 Transmissible spongiform encephalopathy detection in cervids, sheep and goats
05/12/2005WO2005043152A1 A fast system for detecting detectible combustion products and method for making and using same
05/12/2005WO2005043142A2 Pavement material microwave density measurement methods and apparatuses
05/12/2005WO2005043140A1 Object analysis apparatus
05/12/2005WO2005043137A1 Direct observation of molecular modifications in biological test systems by measuring fluorescence lifetime
05/12/2005WO2005043136A1 Early diagnosis method for prion diseases, using infrared spectroscopy
05/12/2005WO2005043130A1 Device and method for determining the gas content of a liquid
05/12/2005WO2005043128A1 Sampling particulate material
05/12/2005WO2005043125A2 A non-fluorescent, non-enzymatic, chemiluminescent aqueous assay
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005043123A2 System and apparatus for body fluid analysis using surface-textured optical materials
05/12/2005WO2005043121A2 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
05/12/2005WO2005043120A2 Micro mechanical methods and systems for performing assays
05/12/2005WO2005043117A2 Gel-shell beads with adsorbed or bound biomolecules
05/12/2005WO2005043111A2 Serum biomarkers for sars
05/12/2005WO2005043110A2 Fluorescence assay for mtp activity
05/12/2005WO2005043109A2 Sers diagnostic platforms, methods and systems including microarrays, biosensors and biochips
05/12/2005WO2005042815A2 Method for visually displaying if predetermined effects are produced
05/12/2005WO2005042795A2 Plasma polymerization of atomically modified surfaces
05/12/2005WO2005042780A1 Phage antibodies to radiation-inducible neoantigens
05/12/2005WO2005042779A1 Method of screening remedy or preventive for diabetes or diabetic nephropathy
05/12/2005WO2005042776A1 Method of determining predisposition towards atherosclerosis
05/12/2005WO2005042773A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042772A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042770A2 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
05/12/2005WO2005042769A1 Methods for inducing complete apoptosis of liver cells expressing hbx protein and screening for substances or genes that inhibit the apoptosis
05/12/2005WO2005042765A2 High throughput screening methods for lubricating oil compositions
05/12/2005WO2005042761A2 Biomarkers for amyotrophic lateral sclerosis
05/12/2005WO2005042760A2 Systems and methods for detecting biological features
05/12/2005WO2005042759A2 Expression profiling using microarrays
05/12/2005WO2005042746A1 Bacterial virulence factors and uses thereof
05/12/2005WO2005042731A1 Methods for purifying hematopoietic stem cells
05/12/2005WO2005042726A2 Methods for modulating an immune response by modulating krc activity
05/12/2005WO2005042725A2 Liver cancer biomarkers
05/12/2005WO2005042717A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005WO2005042716A2 Nucleic acid binding oligonucleotides
05/12/2005WO2005042715A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005WO2005042711A2 Pain-associated gene pnpg1
05/12/2005WO2005042704A2 Differential enzymatic fragmentation
05/12/2005WO2005042701A2 Methods to identify compounds useful for tumor sensitization to dna damage
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042579A1 Anti-sars virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody
05/12/2005WO2005042574A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005WO2005042570A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005WO2005042565A2 Cyclin groove inhibitors
05/12/2005WO2005042559A2 Capture and release based isotope tagged peptides and methods for using the same
05/12/2005WO2005042029A2 Psma formulations and uses thereof
05/12/2005WO2005042016A2 Stabilised compositions
05/12/2005WO2005042002A2 Treatment of rhematoid arthritis with flip antagonists
05/12/2005WO2005041903A2 Methods and reagents for diagnosis and treatment of diabetes
05/12/2005WO2005041901A2 Therapeutics using somatostatin agonists
05/12/2005WO2005041893A2 Detection of acute myocardial infarction biomarkers
05/12/2005WO2005041758A2 Novel cell-based assays employing voltage and calcium dyes
05/12/2005WO2005041757A2 Detection of neuropeptides associated with pelvic pain disorders and uses thereof
05/12/2005WO2005041751A2 Sample testing device with funnel collector
05/12/2005WO2005041750A2 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
05/12/2005WO2005041746A2 Optical sensor and methods for measuring molecular binding interactions
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005041650A1 TRANSGENIC FLIES EXPRESSING MUTANT Aβ42
05/12/2005WO2005036175A9 Sensors employing combinatorial artificial receptors
05/12/2005WO2005029608A3 Probe solution, probe carrier, and method of manufacturing probe carrier
05/12/2005WO2005026192A3 Hpv cd8+ t-cell epitopes
05/12/2005WO2005024418A3 Novel markers for alternatively activated macrophages
05/12/2005WO2005024414A3 Measuring device for determining the characteristics and the level of a brake fluid in a motor vehicle
05/12/2005WO2005022168A3 Hematological analyzer on whole blood with stirring device
05/12/2005WO2005022163A3 Method for determining adult neurogenesis
05/12/2005WO2005022143A3 Method and apparatus for assay of electrochemical properties
05/12/2005WO2005019269A3 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
05/12/2005WO2005019249A8 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
05/12/2005WO2005017523A3 Method for discriminating between ischemic and haemorrhagic stroke
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005010152A3 Human mast cell-expressed membrane protein
05/12/2005WO2005008297A9 Integrated virtual slide and live microscope system
05/12/2005WO2005006985A3 Analysis apparatus and analysis method for body fluids
05/12/2005WO2005003766A3 Methods of regulating metabolism and mitochondrial function
05/12/2005WO2005003164A3 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
05/12/2005WO2005001483A3 Methods for diagnisis and differential diagnosis of dementia disorders
05/12/2005WO2005001132A3 Gene expression profiles that identify genetically elite ungulate mammals
05/12/2005WO2004113566A3 Disease related protein network
05/12/2005WO2004113556A8 Assay and kits for detecting protein binding
05/12/2005WO2004110370A3 Etiologic agnet for sow infertility syndrome
05/12/2005WO2004109291A3 Method for diagnosis and therapy of hazelnut-induced systemic reaction
05/12/2005WO2004106887A3 Quality assurance/quality control for high throughput bioassay process
05/12/2005WO2004106497A3 Imageable animal model of sars infection
05/12/2005WO2004093636A3 PLASMA C5a LEVELS AS AN INDICATOR OF ASTHMA SEVERITY
05/12/2005WO2004087946A3 Method for the detection of post-translational modification activities and device system for carrying out said method
1 ... 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 ... 3937